A newly developed laboratory tool can, within hours, help to identify specific viruses which can be used to destroy variants of the dangerous pathogenic bacteria Staphylococcus aureus.

Shares of Globe Life Inc. GL slid 1.78% to $122.35 Wednesday, on what proved to be an all-around mixed trading session for ...

Molecular Devices' CellXpress AI streamlines cell culture processes, reducing human error and improving efficiency in drug ...

The global Clinical Trial Services Market, valued at US$60.76 billion in 2024, is forecasted to grow at a robust CAGR of 8.9% ...

In a report released today, Andrew Kligerman from TD Cowen maintained a Buy rating on Globe Life (GL – Research Report), with a price target of ...

Globe Life Inc. closed 5.19% below its 52-week high of $131.39, which the company achieved on March 3rd.

The report "Microfiltration Membranes Market by Type (Fluorinated Polymers, Cellulosic, Polysulfones, Ceramic), pore size ...

The global PFAS Testing Market, valued at US$379.2 million in 2023, is forecasted to grow at a robust CAGR of 14.5%, reaching US$429.2 million in 2024 and an impressive US$969.5 million by 2030. The ...

Innovation in HIV care and prevention is transforming the fight, but there is more to be done in order to meet the UNAIDS targets of ending the HIV epidemic by 2030 ...

Finished logos can be instantly downloaded in multiple formats, such as PNG, JPG, SVG, EPS, and PDF, with transparent backgrounds and variations for digital and print use. Beyond logos, Design.com ...

Morgan Stanley raised the firm’s price target on Globe Life (GL) to $126 from $125 and keeps an Equal Weight rating on the shares. Life insurers are in a better operating environment ...